Autobio(SH:603658)2024-04-18 07:37Financial Performance - The company's operating revenue for Q1 2024 was ¥1,089,195,256.05, representing a year-on-year increase of 5.09%[4] - The net profit attributable to shareholders was ¥324,212,004.34, reflecting a significant increase of 33.93% compared to the same period last year[4] - The net cash flow from operating activities reached ¥328,402,122.27, marking a substantial increase of 61.21% year-on-year[4] - Basic earnings per share (EPS) for the period was ¥0.56, which is an increase of 33.33% compared to the previous year[5] - The operating profit for Q1 2024 was ¥363,984,360.14, compared to ¥270,901,472.75 in Q1 2023, indicating an increase of approximately 34.3%[19] - The net profit for Q1 2024 reached ¥328,699,468.29, up from ¥247,172,878.22 in Q1 2023, marking a growth of around 32.9%[20] - The total comprehensive income for Q1 2024 was ¥328,712,789.76, compared to ¥247,052,244.69 in Q1 2023, showing an increase of approximately 32.9%[20] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥11,605,922,648.81, showing a slight increase of 0.45% from the end of the previous year[5] - The total liabilities decreased to ¥2,752,063,672.66 in Q1 2024 from ¥2,887,726,931.49 in Q1 2023, a reduction of approximately 4.7%[19] - The total assets reached approximately CNY 11.61 billion, compared to CNY 11.55 billion at the end of 2023, marking an increase of about 0.4%[16] - The short-term borrowings decreased to approximately CNY 244.08 million from CNY 343.30 million, a reduction of about 29%[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 22,419[9] - The largest shareholder, Zhengzhou Antu Industrial Group Co., Ltd., held 55.25% of the shares[9] - The major shareholder, Zhengzhou Antu Industrial Group, holds 55.25% of the total shares, with no significant changes in shareholding structure reported[13] Cash Flow and Investments - In Q1 2024, the company reported cash inflows from operating activities of approximately $1.33 billion, an increase of 11.6% compared to $1.19 billion in Q1 2023[21] - The net cash flow from operating activities was $328.4 million, up from $203.7 million in the same period last year, representing a growth of 61.3%[21] - Cash outflows from investing activities totaled approximately $863.4 million, compared to $614.6 million in Q1 2023, indicating a 40.5% increase[22] - The net cash flow from investing activities was negative at $622.98 million, slightly worse than the negative $587.69 million reported in Q1 2023[22] - Cash inflows from financing activities amounted to $579.2 million, an increase from $365 million in Q1 2023, reflecting a growth of 58.7%[22] - The net cash flow from financing activities was negative at $113.19 million, compared to a smaller negative of $23.34 million in the previous year[22] Operational Costs and Expenses - The total operating costs decreased to ¥777,943,233.44 in Q1 2024 from ¥785,646,662.30 in Q1 2023, reflecting a reduction of about 1.0%[19] - Research and development expenses for Q1 2024 were ¥151,149,747.29, slightly down from ¥152,423,398.43 in Q1 2023, indicating a decrease of approximately 0.8%[19] - The company paid $434.31 million in employee compensation, up from $407.80 million in the same quarter last year, reflecting a rise of 6.5%[21] - The company reported a decrease in tax payments to $109.47 million from $137.54 million in Q1 2023, a reduction of 20.4%[21] Other Notable Information - The company reported a non-recurring gain of ¥10,206,805.99 for the period[7] - The company has not indicated any new product launches or significant market expansion strategies during this reporting period[14] - The cash and cash equivalents decreased to approximately CNY 1.08 billion from CNY 1.49 billion year-over-year, representing a decline of about 27.4%[15] - The accounts receivable stood at approximately CNY 1.11 billion, down from CNY 1.15 billion, indicating a decrease of about 4.3%[15] - Inventory increased to approximately CNY 833.39 million, up from CNY 778.29 million, reflecting a growth of about 7.1%[15]